The neurophysiology of hyperarousal in RLS: Hints for a role of glutamate/GABA

Giuseppe Lanza, Raffale Ferri

Research output: Contribution to journalArticle

Abstract

Restless legs syndrome (RLS) is a common sensory-motor circadian disorder, whose basic components include urge to move the legs, unpleasant sensory experience, and periodic leg movements during sleep, all associated with an enhancement of the individual's arousal state. Brain iron deficiency (BID) is considered to be a key initial pathobiological factor, based on alterations of iron acquisition by the brain, also moderated by genetic factors. In addition to the well-known dopaminergic involvement in RLS, previous studies pointed out that BID brings also a hyperglutamatergic state that influences a dysfunctional cortico-striatal-thalamic-cortical circuit in genetically vulnerable individuals. However, the enhancement of arousal mechanisms in RLS may also be explained by functional changes of the ascending arousal systems and by deficitary GABA-mediated inhibitory control. Very recently, it was also suggested that BID induces a hypoadenosinergic state in RLS, thus possibly providing a link for a putative unified pathophysiological mechanism accounting for both hyperarousal and sensory-motor signs. Consequently, RLS might be viewed as a multitransmitter neurochemical disorder, globally resulting in enhanced excitability and decreased inhibition. In this framework, understanding the complex interaction of different neuronal circuits in generating the symptoms of RLS is mandatory both for a better diagnostic refinement and for an innovative therapeutic support. Notably, multiple neurotransmission dysfunction, either primary or triggered by BID, may also bridge the gap between RLS and other chronic pain disorders. This chapter summarizes the current experimental and clinical findings into a heuristic model of the electrophysiology and neurochemistry underlying RLS.

Original languageEnglish
JournalAdvances in Pharmacology
DOIs
Publication statusAccepted/In press - Jan 1 2019

Fingerprint

Restless Legs Syndrome
Neurophysiology
gamma-Aminobutyric Acid
Glutamic Acid
Iron
Arousal
Brain
Leg
Neurochemistry
Corpus Striatum
Somatoform Disorders
Electrophysiology
Synaptic Transmission
Chronic Pain
Sleep

Keywords

  • Arousal
  • Dopamine
  • Excitability
  • GABA
  • Glutamate
  • Iron metabolism
  • Restless legs syndrome

ASJC Scopus subject areas

  • Pharmacology

Cite this

The neurophysiology of hyperarousal in RLS : Hints for a role of glutamate/GABA. / Lanza, Giuseppe; Ferri, Raffale.

In: Advances in Pharmacology, 01.01.2019.

Research output: Contribution to journalArticle

@article{42ac5884ff2a40fb9b58ede3f37a27eb,
title = "The neurophysiology of hyperarousal in RLS: Hints for a role of glutamate/GABA",
abstract = "Restless legs syndrome (RLS) is a common sensory-motor circadian disorder, whose basic components include urge to move the legs, unpleasant sensory experience, and periodic leg movements during sleep, all associated with an enhancement of the individual's arousal state. Brain iron deficiency (BID) is considered to be a key initial pathobiological factor, based on alterations of iron acquisition by the brain, also moderated by genetic factors. In addition to the well-known dopaminergic involvement in RLS, previous studies pointed out that BID brings also a hyperglutamatergic state that influences a dysfunctional cortico-striatal-thalamic-cortical circuit in genetically vulnerable individuals. However, the enhancement of arousal mechanisms in RLS may also be explained by functional changes of the ascending arousal systems and by deficitary GABA-mediated inhibitory control. Very recently, it was also suggested that BID induces a hypoadenosinergic state in RLS, thus possibly providing a link for a putative unified pathophysiological mechanism accounting for both hyperarousal and sensory-motor signs. Consequently, RLS might be viewed as a multitransmitter neurochemical disorder, globally resulting in enhanced excitability and decreased inhibition. In this framework, understanding the complex interaction of different neuronal circuits in generating the symptoms of RLS is mandatory both for a better diagnostic refinement and for an innovative therapeutic support. Notably, multiple neurotransmission dysfunction, either primary or triggered by BID, may also bridge the gap between RLS and other chronic pain disorders. This chapter summarizes the current experimental and clinical findings into a heuristic model of the electrophysiology and neurochemistry underlying RLS.",
keywords = "Arousal, Dopamine, Excitability, GABA, Glutamate, Iron metabolism, Restless legs syndrome",
author = "Giuseppe Lanza and Raffale Ferri",
year = "2019",
month = "1",
day = "1",
doi = "10.1016/bs.apha.2018.12.002",
language = "English",
journal = "Advances in Pharmacology",
issn = "1054-3589",
publisher = "Academic Press Inc.",

}

TY - JOUR

T1 - The neurophysiology of hyperarousal in RLS

T2 - Hints for a role of glutamate/GABA

AU - Lanza, Giuseppe

AU - Ferri, Raffale

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Restless legs syndrome (RLS) is a common sensory-motor circadian disorder, whose basic components include urge to move the legs, unpleasant sensory experience, and periodic leg movements during sleep, all associated with an enhancement of the individual's arousal state. Brain iron deficiency (BID) is considered to be a key initial pathobiological factor, based on alterations of iron acquisition by the brain, also moderated by genetic factors. In addition to the well-known dopaminergic involvement in RLS, previous studies pointed out that BID brings also a hyperglutamatergic state that influences a dysfunctional cortico-striatal-thalamic-cortical circuit in genetically vulnerable individuals. However, the enhancement of arousal mechanisms in RLS may also be explained by functional changes of the ascending arousal systems and by deficitary GABA-mediated inhibitory control. Very recently, it was also suggested that BID induces a hypoadenosinergic state in RLS, thus possibly providing a link for a putative unified pathophysiological mechanism accounting for both hyperarousal and sensory-motor signs. Consequently, RLS might be viewed as a multitransmitter neurochemical disorder, globally resulting in enhanced excitability and decreased inhibition. In this framework, understanding the complex interaction of different neuronal circuits in generating the symptoms of RLS is mandatory both for a better diagnostic refinement and for an innovative therapeutic support. Notably, multiple neurotransmission dysfunction, either primary or triggered by BID, may also bridge the gap between RLS and other chronic pain disorders. This chapter summarizes the current experimental and clinical findings into a heuristic model of the electrophysiology and neurochemistry underlying RLS.

AB - Restless legs syndrome (RLS) is a common sensory-motor circadian disorder, whose basic components include urge to move the legs, unpleasant sensory experience, and periodic leg movements during sleep, all associated with an enhancement of the individual's arousal state. Brain iron deficiency (BID) is considered to be a key initial pathobiological factor, based on alterations of iron acquisition by the brain, also moderated by genetic factors. In addition to the well-known dopaminergic involvement in RLS, previous studies pointed out that BID brings also a hyperglutamatergic state that influences a dysfunctional cortico-striatal-thalamic-cortical circuit in genetically vulnerable individuals. However, the enhancement of arousal mechanisms in RLS may also be explained by functional changes of the ascending arousal systems and by deficitary GABA-mediated inhibitory control. Very recently, it was also suggested that BID induces a hypoadenosinergic state in RLS, thus possibly providing a link for a putative unified pathophysiological mechanism accounting for both hyperarousal and sensory-motor signs. Consequently, RLS might be viewed as a multitransmitter neurochemical disorder, globally resulting in enhanced excitability and decreased inhibition. In this framework, understanding the complex interaction of different neuronal circuits in generating the symptoms of RLS is mandatory both for a better diagnostic refinement and for an innovative therapeutic support. Notably, multiple neurotransmission dysfunction, either primary or triggered by BID, may also bridge the gap between RLS and other chronic pain disorders. This chapter summarizes the current experimental and clinical findings into a heuristic model of the electrophysiology and neurochemistry underlying RLS.

KW - Arousal

KW - Dopamine

KW - Excitability

KW - GABA

KW - Glutamate

KW - Iron metabolism

KW - Restless legs syndrome

UR - http://www.scopus.com/inward/record.url?scp=85060086705&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85060086705&partnerID=8YFLogxK

U2 - 10.1016/bs.apha.2018.12.002

DO - 10.1016/bs.apha.2018.12.002

M3 - Article

AN - SCOPUS:85060086705

JO - Advances in Pharmacology

JF - Advances in Pharmacology

SN - 1054-3589

ER -